Percutaneous irreversible electroporation for the treatment of pancreatic insulinoma

Elsevier

Available online 28 March 2023

Diagnostic and Interventional ImagingAuthor links open overlay panel, , , , Section snippetsHuman rights

The authors declare that the work described has been performed in accordance with the Declaration of Helsinki of the World Medical Association revised in 2013 for experiments involving humans.

Informed consent and patient details

The authors declare that this report does not contain any personal information that could lead to the identification of the patient.

Author contributions

All authors attest that they meet the current International Committee of Medical Journal Editors (ICMJE) criteria for Authorship.

CRediT authorship contribution statement

Jean-Pierre Tasu: Conceptualization, Data curation, Investigation, Methodology, Supervision, Writing – original draft, Writing – review & editing. Mathilde Vionnet: Data curation, Investigation. Stéphane Velasco: Investigation, Writing – review & editing. Luc Lafitte: Software. Clair Poignard: Supervision, Software, Writing – review & editing.

Declaration of Competing Interest

The authors have no conflicts of interest to disclose in relation with this article.

Funding

This work did not receive any grant from funding agencies in the public, commercial, or not-for-profit sectors.

Acknowledgments

The authors thank Jeffrey Arsham for his useful review of the English language.

References (4)

There are more references available in the full text version of this article.

View full text

© 2023 Société française de radiologie. Published by Elsevier Masson SAS. All rights reserved.

留言 (0)

沒有登入
gif